U.S. market Closed. Opens in 2 hours 49 minutes

MEIP | MEI Pharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-30
Revenue65.30M48.82M40.70M25.54M28.91M4.92M1.62M23.25MN/AN/AN/AN/AN/AN/A84.00K228.00K674.00K645.00KN/A308.00K193.00K145.00K7.00K
Cost of Revenue15.97M1.81M1.24M1.41M2.67M4.26M3.38M5.00MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A500.00KN/A
Gross Profit49.33M47.00M39.46M24.13M26.24M652.00K-1.76M18.25MN/AN/AN/AN/AN/AN/A84.00K228.00KN/AN/AN/AN/AN/A-355.00KN/A
Operating Expenses39.86M85.58M116.18M93.81M50.78M46.90M26.82M15.87M21.00M32.77M27.23M11.22M8.39M6.45M7.98M11.41M13.76M14.46M7.38M6.73M8.73M2.68M129.00K
Selling, General & Admin23.30M33.13M30.54M24.41M16.72M14.60M9.79M8.63M5.67M7.17M6.45M5.14MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Research & Development16.56M52.45M85.64M69.40M34.06M32.30M17.04M7.24M13.40M23.82M19.33M6.08M4.92M2.12M4.03M7.78M9.32M5.76M3.43M2.28M2.38M2.02MN/A
Other Operating Expenses-41.00K-22.00K-6.00K486.00KN/AN/A15.42MN/A1.93M1.77M1.45MN/A3.48M4.34M3.95M3.63M4.43M8.70M3.96M4.45M6.35M654.00K129.00K
Operating Income14.54M-36.76M-75.48M-69.69M-24.54M-46.24M-28.59M2.38M-21.00M-32.77M-27.23M-11.22M-8.39M-6.45M-7.89M-11.18M-13.08M-13.82M-7.38M-6.42M-8.54M-3.03M-122.00K
Other Expenses / Income-10.94M1.58M21.03M19.12M-21.48M29.43M-9.71M287.00K143.00K78.00K81.00K37.00K872.00K-329.00KN/AN/A674.00KN/AN/AN/AN/AN/AN/A
Before Tax Income17.78M-31.84M-54.45M-50.57M-46.02M-16.82M-40.07M2.67M-20.86M-32.69M-27.15M-11.19M-7.52M-6.78M-7.89M-11.18M-12.41M-13.82M-7.38M-6.42M-8.54M-3.03M-122.00K
Income Tax Expenses7.62M-4.95M284.00K8.00K1.00K1.00K1.00K1.00K1.00K1.00K1.00K1.00K1.00K1.00K1.00K1.00K3.00K1.00K1.00KN/AN/AN/A1.00K
Net Income17.78M-31.84M-54.45M-41.31M-47.17M-16.82M-40.07M2.67M-20.86M-32.69M-27.15M-11.19M-7.52M-6.78M-7.90M-11.18M-12.41M-13.82M-7.39M-6.42M-8.54M-3.03M-123.00K
Interest ExpensesN/AN/A284.00KN/AN/A-57.06MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding6.66M6.66M6.22M5.63M4.55M3.56M2.07M36.81M34.40M28.20M20.06M10.16M2.25M1.27M1.22M1.22M1.14M1.05M948.97K948.97K915.91K867.05K829.49K
Diluted Shares Outstanding6.66M6.66M6.26M5.72M4.55M3.62M2.07M36.94M34.40M28.20M20.06M10.16M2.25M1.27M1.22M1.22M1.14M1.05M948.97K948.97K915.91K867.05K829.49K
EBITDA36.72M-37.98M-95.91M-87.52M-1.56M-73.80M-18.83M2.76M-20.95M-32.71M-27.18M-11.18M-8.38M-5.98M-7.89M-11.18M-12.41M-13.82M-7.38M-6.42M-8.54M-3.03M-122.00K
EBITDA Margin56.24%-77.80%-235.67%-342.75%-5.40%-1,501.46%-1,160.79%11.85%0.00%0.00%0.00%0.00%0.00%0.00%-9,398.81%-4,903.07%-1,840.80%-2,142.48%0.00%-2,084.74%-4,423.83%-2,091.72%-1,742.86%
EBIT25.40M-36.79M-53.88M-41.30M-47.17M-73.88M-40.07M2.67M-20.86M-32.69M-27.15M-11.19M-7.52M-6.78M-7.89M-11.18M-12.41M-13.82M-7.38M-6.42M-8.54M-3.03M-122.00K
EBIT Margin38.90%-75.36%-132.40%-161.75%-163.14%-1,503.09%-2,470.22%11.49%0.00%0.00%0.00%0.00%0.00%0.00%-9,398.81%-4,903.07%-1,840.80%-2,142.48%0.00%-2,084.74%-4,423.83%-2,091.72%-1,742.86%
Financial Year End2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙